EP3288636A4 - Zusammensetzungen zur behandlung von epistaxis - Google Patents

Zusammensetzungen zur behandlung von epistaxis Download PDF

Info

Publication number
EP3288636A4
EP3288636A4 EP15891259.2A EP15891259A EP3288636A4 EP 3288636 A4 EP3288636 A4 EP 3288636A4 EP 15891259 A EP15891259 A EP 15891259A EP 3288636 A4 EP3288636 A4 EP 3288636A4
Authority
EP
European Patent Office
Prior art keywords
epistaxis
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15891259.2A
Other languages
English (en)
French (fr)
Other versions
EP3288636A1 (de
Inventor
Evgenia LOZINSKY
Eran Eilat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topitech Pharma Israel Ltd
Original Assignee
Topitech Pharma Israel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topitech Pharma Israel Ltd filed Critical Topitech Pharma Israel Ltd
Publication of EP3288636A1 publication Critical patent/EP3288636A1/de
Publication of EP3288636A4 publication Critical patent/EP3288636A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP15891259.2A 2015-05-01 2015-05-01 Zusammensetzungen zur behandlung von epistaxis Withdrawn EP3288636A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/001451 WO2016178053A1 (en) 2015-05-01 2015-05-01 Compositions for the treatment of epistaxis

Publications (2)

Publication Number Publication Date
EP3288636A1 EP3288636A1 (de) 2018-03-07
EP3288636A4 true EP3288636A4 (de) 2019-01-16

Family

ID=57218149

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15891259.2A Withdrawn EP3288636A4 (de) 2015-05-01 2015-05-01 Zusammensetzungen zur behandlung von epistaxis

Country Status (5)

Country Link
EP (1) EP3288636A4 (de)
CN (1) CN107073293A (de)
CA (1) CA2952818A1 (de)
IL (1) IL249640A0 (de)
WO (1) WO2016178053A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019020766B1 (pt) * 2017-04-04 2022-11-29 Anti-Plasmin Technologies, Llc Composição para aperfeiçoar um tratamento médico não cirúrgico
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212952A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
AU2021276656A1 (en) 2020-05-19 2022-11-24 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
US11642324B1 (en) * 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
EP1786480B1 (de) * 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Hämostatische zusammensetzung mit hyaluronsäure
PT2493474T (pt) * 2009-10-30 2019-11-26 Intratus Inc Métodos e composições para libertação prolongada de fármacos
WO2014064703A1 (en) * 2012-10-28 2014-05-01 Peritech Pharma Ltd. Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
CN105142611B (zh) * 2013-03-10 2019-06-04 佩丽泰克医药有限公司 外用组合物及治疗局部病症的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2016178053A1 (en) 2016-11-10
IL249640A0 (en) 2017-02-28
EP3288636A1 (de) 2018-03-07
CA2952818A1 (en) 2016-11-10
CN107073293A (zh) 2017-08-18

Similar Documents

Publication Publication Date Title
EP3448874A4 (de) Zusammensetzungen zur behandlung einer erkrankung
EP3448875A4 (de) Zusammensetzungen zur behandlung einer erkrankung
EP3448987A4 (de) Zusammensetzungen zur behandlung einer erkrankung
EP3263132A4 (de) Zusammensetzung zur behandlung von il-6-assoziierten erkrankungen
EP3240555A4 (de) Mehrfachergänzungszusammensetzungen
EP3380199A4 (de) Zusammensetzungen zur behandlung der haare
EP3380200A4 (de) Zusammensetzungen zur behandlung der haare
EP3380062A4 (de) Zusammensetzungen zur behandlung der haare
AU2016291708B2 (en) Plinabulin compositions
EP3380063A4 (de) Zusammensetzungen zur behandlung der haare
HUE044021T2 (hu) Akne kezelésére szolgáló készítmény
EP3248475A4 (de) Zusammensetzung
IL249640A0 (en) Preparations for the treatment of nosebleeds
TWI799397B (zh) 用於治療高血壓之組合物
EP3344256A4 (de) Zusammensetzungen zur behandlung von gelenken
EP3122349A4 (de) Zusammensetzungen zur behandlung von autodigestion
EP3386593A4 (de) Immunmodulierende zusammensetzung zur behandlung
EP3349766A4 (de) Antihämorrhagische zusammensetzungen
EP3288386A4 (de) Antiphytopathogene zusammensetzungen
EP3206670A4 (de) Zusammensetzung zur behandlung von wunden
EP3341006A4 (de) Zusammensetzungen und verfahren zur behandlung von nervenschäden
EP3277256A4 (de) Haarbehandlungszusammensetzungen
EP3354284A4 (de) Zusammensetzung zur schmerzbehandlung
EP3315031A4 (de) Zusammensetzung
EP3294339A4 (de) Verfahren und zusammensetzungen zur behandlung von arthritis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20181219

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 11/02 20060101AFI20181213BHEP

Ipc: A61K 9/06 20060101ALI20181213BHEP

Ipc: A61K 31/4174 20060101ALI20181213BHEP

Ipc: A61K 31/195 20060101ALI20181213BHEP

Ipc: A61K 47/34 20170101ALI20181213BHEP

Ipc: A61K 31/137 20060101ALI20181213BHEP

Ipc: A61K 9/70 20060101ALI20181213BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190719